Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-014376

Chief Science & Business Off bought 4,600 shares at an average $3.44 ($15,834)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Poradosu Enrique Chief Science & Business Off 2022-02-04 Purchase +3,800 $3.35 $12,730 1,196,849 D
Poradosu Enrique Chief Science & Business Off 2022-02-07 Purchase +800 $3.88 $3,104 1,197,649 D
Open-market purchases · 4,600 sh · avg $3.44 · $15,834
Loading xslF345X03/tm225864-3_4seq1.xml…